CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the acquisition, development, and commercialization of therapeutics addressing cancer and other unmet medical needs with a commercial focus on the China market. The company’s technologies include an anti-angiogenesis program that focuses on the development of proprietary products that are intended to inhibit the abnormal growth of new blood vessels associated with cancer and certain causes of blindness. Another EntreMed technology is a blood-cell-permeation device that is designed to enhance the ability of red blood cells to deliver oxygen to organs and tissues.